Cardiovascular
To learn more about Harrington Investigator, Jonathan Stamler, click the button below.
Grant award provides new discovery pathway for MSTP students to translate promising scientific discoveries into medicines.Cleveland, Ohio, USA – September 17, 2019 – Harrington Discovery Institute at University Hospitals and Case Western Reserve University School of Medicine today announced a new program to help the next generation of physician-scientists advance their discoveries into... Continue Reading
On June 4, 2019 Morgan Stanley announced an exciting new collaboration with Harrington Discovery Institute at The Exchange 2019, a two-day event in New York City presented by The Social Impact Exchange and Morgan Stanley. Through a new partnership with Morgan Stanley Global Impact Funding Trust (GIFT), Harrington Discovery Institute is transforming the way philanthropy supports the development of... Continue Reading
Key PointsTek Image / Science Photo Library / Getty ImagesMorgan Stanley is starting a new program that will let clients donate money to find treatments and cures for diseases.The program, called Morgan Stanley GIFT Cures, began today in tandem with a two-day conference the financial services firm is hosting.All donations made to Morgan Stanley GIFT Cures will be managed through a donor-advised... Continue Reading
Oxford, UK and Cleveland, Ohio, USA – 28 February 2019 – The University of Oxford and University Hospitals in Cleveland, Ohio, today announced a multi-year affiliation to establish a global center for rare diseases. The Oxford-Harrington Rare Disease Centre will bring together the capabilities, resources and expertise of both institutions to deliver new treatments for rare diseases, for which... Continue Reading
From CEOs and politicians to philanthropists and entrepreneurs, Crain’s Who’s Who list is just a snapshot of those making an impact on Northeast Ohio. There were no specific criteria used, but our editorial team huddled and determined which leaders we thought every person doing business in the region should know. Special consideration was given to those who go well beyond their official roles... Continue Reading
Takeda and Harrington Discovery Institute at University Hospitals Announce a Collaboration to Advance the Development of Rare Disease TherapeuticsOsaka, Japan and Cleveland, Ohio, USA – 27 April 2017 – Takeda Pharmaceutical Company Limited (TSE: 4502), and Harrington Discovery Institute at University Hospitals in Cleveland, Ohio have announced a multi-year collaboration to accelerate... Continue Reading
CLEVELAND – Harrington Discovery Institute at University Hospitals in Cleveland, Ohio and the Alzheimer’s Drug Discovery Foundation (ADDF) have expanded their collaboration to accelerate translation of innovative research efforts for Alzheimer’s disease. Together, the two organizations will jointly market and administer a new award program for academic researchers. By leveraging their... Continue Reading
Cleveland – The Trustees of the Burton D. Morgan Foundation in Hudson Ohio have awarded a grant of $200,000 to the Harrington Discovery Institute at University Hospitals in Cleveland, Ohio to support the Institute’s Innovation Support Center (ISC) and its mission of mentoring physician-scientists to advance novel discoveries into new drugs that improve human health.The Harrington Discovery... Continue Reading
For the past decade, venture philanthropists have been working to propel promising therapies and vaccines into the clinic, with some success.Venture philanthropist Bill Gates looks on as a health worker vaccinates a child in GhanaIn December 2015, Facebook founder Mark Zuckerberg and his wife Priscilla Chan made a stunning announcement. In a letter to their newborn daughter, the couple pledged to... Continue Reading
Dr. Jonathan Stamler, director of The Harrington Discovery Institute at University Hospitals in Cleveland, has earned a reputation as a “genius.”“Some people are geniuses,” his fatherâinâlaw Norman Wain said. “Geniuses have a capacity to work.”“He has this sort of infectious personality to want to drive scientists to not just make discoveries, which is great, but you... Continue Reading
INDIANAPOLIS— A group of researchers led by Indiana University School of Medicine’s , has been awarded a research program project grant (P01) from the National Heart, Lung and Blood Institute. The award amounts to just over $12 million over the next five years and will fund the development of personalized therapeutic approaches for severe asthma.Severe asthma is one of the most common and... Continue Reading
Jonathan Stamler, MD, President and Investigator of Harrington Discovery Institute, and his colleagues are currently developing an exercise wearable to help personalize exercise to minimize the risks of dementia.Research reveals that exercise is beneficial not just for the body, but also for the mind. According to the , exercising for 30 minutes five times a week can lower one’s risk of... Continue Reading
CLEVELAND, Ohio USA – After statins, the next leading class of medications for managing cholesterol are PCSK9 inhibitors. These highly effective agents help the body pull excess cholesterol from the blood, but unlike statins, which are available as oral agents, PCSK9 inhibitors can only be administered as shots, creating barriers to their use.Now, a new study from investigators at University... Continue Reading
CLEVELAND—Cardiovascular medicine, hematology and pulmonary medicine may soon have the first-ever therapies to correct poor tissue oxygenation, a key driver of disease in millions, including peripheral artery disease, sickle cell disease, heart failure, stroke, emphysema and many others.The breakthrough follows a landmark discovery from investigators at Harrington Discovery Institute at... Continue Reading
In a recent episode of the Science@UH Podcast, Dr. Daniel Simon, President of Academic & External Affairs and Chief Scientific Officer at University Hospitals, engaged in an insightful discussion with Dr. Jonathan Stamler, President and Founder of Harrington Discovery Institute. The conversation revolved around the paradigm-shifting discovery of protein S-nitrosylation, its implications for... Continue Reading